Navigation Links
GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act'
Date:3/26/2009

Companion Senate Bill Puts Patient Health and Safety and Pharmaceutical Innovation First

ARLINGTON, Va., March 26 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger regarding the bipartisan Senate introduction of the "Promoting Innovation and Access to Life-Saving Medicine Act."

"Momentum is skyrocketing for biogenerics legislation that puts patients and pharmaceutical innovation first. The legislation introduced today in the Senate and last week in the House demonstrates that life-saving biogenerics can get to patients in need sooner rather than later while also fostering competition to drive pharmaceutical innovation. We applaud Senators Chuck Schumer (D-NY), Sherrod Brown (D-OH), Susan Collins (R-ME), Mel Martinez (R-FL), Jeanne Shaheen (D-NH), Debbie Stabenow (D-MI) and David Vitter (R-LA) for their commitment to increasing access to these life-saving medicines while also ultimately reducing overall health care costs.

"This bipartisan consensus bill holds generic companies to the same quality, safety and science-based standards as brand companies when they make subsequent product changes of their biopharmaceutical medicines. This consensus bill also provides FDA with the same scientific discretion regarding approval criteria for biogenerics and biosimilars as they have for biopharmaceuticals. There should be one gold standard for science, quality and safety and this legislation provides that standard while also creating a system of market exclusivity that has allowed both the brand and generic industries to flourish together for 25 years to the benefit of consumers.

"Reducing overall health care costs while increasing access to quality care is essential to achieving real health care reform. With studies showing that biogenerics legislation will produce significant savings, it is critical that Congress act to ensure these affordable life-saving medicines get to patients in a timely manner.

"Momentum is not only growing in Congress, but across the country, with millions of Americans represented by leading consumer, business and labor organizations and AARP supporting this legislation that puts equality into the system and needed medicines into the hands of consumers.

"It's time to enact legislation that gives FDA the authority and flexibility to create a workable biogenerics approval pathway that upholds their gold standard of ensuring safety and quality. We don't need a pathway that's so filled with roadblocks that it is merely an empty promise for patients. Let's fulfill our promise to patients and to strengthening our health care system by passing the 'Promoting Innovation and Access to Life-Saving Medicine Act'."

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 69% of the total prescriptions dispensed in the United States, but only 16% of all dollars spent on prescription drugs. For more information about the industry, visit www.gphaonline.org.


'/>"/>
SOURCE Generic Pharmaceutical Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... WESTWOOD, Mass. , Oct. 4, 2017  According to the Centers ... by the end of October . PhysicianOne Urgent Care is helping communities ... Westchester, NY , by offering no-cost* flu shots through ... , as mandated by certain health insurance regulations. ... The best time to get a flu shot is by ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
Breaking Medicine Technology: